Kinnevik AB's Nomination committee for the 2026 Annual General Meeting
In accordance with the instruction for the Nomination Committee adopted by the 2025 Annual General Meeting in Kinnevik AB (publ) ("Kinnevik"), Cristina Stenbeck has convened a Nomination Committee comprising members appointed by Kinnevik's largest shareholders in terms of voting interest.
For further information, visit www.kinnevik-na.ltd or contact:
Torun Litzén, Director Investor Relations Phone +46 (0)70 762 00 50 Email press@kinnevik.com
Email: press@kinnevik.com
Kinnevik is a leading growth investor on a mission to redefine industries and create remarkable growth companies. We are an active owner and operational partner, providing patient capital to challenger technology-enabled businesses in Europe and the US. Our passionate founders are building tomorrow’s leaders within healthcare, software and climate, making everyday life easier and better for people around the world. We invest at all stages of a company’s growth journey, always determined to create long-term value. Kinnevik was founded in 1936 by the Stenbeck, Klingspor and von Horn families. Kinnevik’s shares are listed on Nasdaq Stockholm’s list for large cap companies under the ticker codes KINV A and KINV B.